

28 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ut-health-san-antonio-research-shows-alzheimers-prevention-potential-in-pairing-cannabis-ingredient-anti-inflammatory-drug-302673222.html

20 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-of-its-kind-medical-grade-cannabis-pharmacy-launches-in-colorado-302665539.html

12 Jan 2026
// PR NEWSWIRE BIO
https://www.prnewswire.com/news-releases/mandara-biopharma-files-ind-with-the-fda-to-advance-dronabinol-oral-solution-formulation-for-alzheimers-agitation-302658358.html

07 Jan 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-01-07/ovation-science-secures-new-canadian-patent-strengthening-ip-position-and-expanding-commercial-oppo

22 Sep 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-reports-50-patient-enrollment-milestone-in-phase-2-calma-alzheimers-agitat-1076002

13 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/benuvia-operations-signs-commercial-supply-agreement-with-leading-us-pharmaceutical-company-for-dronabinol-api-302453302.html